IL35477A - Pharmaceutical compositions containing garcinia acid or a derivative thereof - Google Patents
Pharmaceutical compositions containing garcinia acid or a derivative thereofInfo
- Publication number
- IL35477A IL35477A IL35477A IL3547770A IL35477A IL 35477 A IL35477 A IL 35477A IL 35477 A IL35477 A IL 35477A IL 3547770 A IL3547770 A IL 3547770A IL 35477 A IL35477 A IL 35477A
- Authority
- IL
- Israel
- Prior art keywords
- derivative
- pharmaceutical compositions
- compositions containing
- containing garcinia
- garcinia acid
- Prior art date
Links
- ZMJBYMUCKBYSCP-CVYQJGLWSA-N Garcinia acid Chemical compound OC(=O)[C@@H](O)[C@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-CVYQJGLWSA-N 0.000 title 1
- PFHZIWAVXDSFTB-UHFFFAOYSA-N hibiscusoic acid Natural products OC(=O)C1OC(=O)CC1(O)C(O)=O PFHZIWAVXDSFTB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87241369A | 1969-10-29 | 1969-10-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL35477A0 IL35477A0 (en) | 1970-12-24 |
| IL35477A true IL35477A (en) | 1973-08-29 |
Family
ID=25359519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL35477A IL35477A (en) | 1969-10-29 | 1970-10-19 | Pharmaceutical compositions containing garcinia acid or a derivative thereof |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE758122A (cs) |
| CA (1) | CA923425A (cs) |
| DE (1) | DE2052131A1 (cs) |
| FR (1) | FR2070174B1 (cs) |
| GB (1) | GB1311015A (cs) |
| IE (1) | IE34648B1 (cs) |
| IL (1) | IL35477A (cs) |
| NL (1) | NL7015348A (cs) |
| ZA (1) | ZA706931B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792180A (fr) * | 1971-12-02 | 1973-06-01 | Hoffmann La Roche | Derives de l'acide citrique |
| FR2716374B1 (fr) * | 1994-02-18 | 1996-04-19 | Sederma Sa | Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes. |
| IT1276253B1 (it) * | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
| ES2106689B1 (es) * | 1996-04-18 | 1998-05-16 | Cabo Soler Jose | Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea. |
| US20030004215A1 (en) * | 2001-06-15 | 2003-01-02 | Van Laere Katrien Maria Jozefa | Dietetic preparation and method for inhibiting intestinal carbohydrate absorption |
-
0
- BE BE758122D patent/BE758122A/xx unknown
-
1970
- 1970-10-12 ZA ZA706931A patent/ZA706931B/xx unknown
- 1970-10-19 IL IL35477A patent/IL35477A/xx unknown
- 1970-10-20 NL NL7015348A patent/NL7015348A/xx not_active Application Discontinuation
- 1970-10-23 DE DE19702052131 patent/DE2052131A1/de active Pending
- 1970-10-26 IE IE1367/70A patent/IE34648B1/xx unknown
- 1970-10-27 GB GB598270*[A patent/GB1311015A/en not_active Expired
- 1970-10-28 FR FR707038856A patent/FR2070174B1/fr not_active Expired
- 1970-10-29 CA CA096898A patent/CA923425A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE34648L (en) | 1971-04-29 |
| BE758122A (fr) | 1971-04-28 |
| IE34648B1 (en) | 1975-07-09 |
| ZA706931B (en) | 1971-07-28 |
| GB1311015A (en) | 1973-03-21 |
| FR2070174B1 (cs) | 1974-02-22 |
| FR2070174A1 (cs) | 1971-09-10 |
| CA923425A (en) | 1973-03-27 |
| NL7015348A (cs) | 1971-05-04 |
| IL35477A0 (en) | 1970-12-24 |
| DE2052131A1 (de) | 1971-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL47937A0 (en) | Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof | |
| IL43766A0 (en) | Pharmaceutical compositions containing bis-phenolalkane derivatives | |
| ZA702530B (en) | Improvements relating to pharmaceutical compositions comprising beta-adrenolytics | |
| IL38090A (en) | Pharmaceutical compositions containing nicotinic acid derivatives | |
| IL35477A0 (en) | Pharmaceutical compositions containing garcinia acid or a derivative thereof | |
| IL34089A (en) | Pharmaceutical compositions containing penicillin or cephalosphorin derivatives | |
| IL34938A (en) | Pharmaceutical compositions containing a 2,4-thiazolidine-dione-2-thiosemicarbazone derivative | |
| CA930306A (en) | Pharmaceutical compositions | |
| IL48230A0 (en) | Pharmaceutical compositions containing 2-naphthyl-butyric acid derivatives | |
| CY845A (en) | Antiineectious pharmaceutical compositions | |
| CA930305A (en) | Pharmaceutical compositions | |
| IL33328A0 (en) | Pharmaceutical compositions containing triazolo-pyrazine derivatives | |
| IL41564A0 (en) | Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives | |
| IL37459A (en) | Pharmaceutical compositions containing 4-hydroxynicotinic acid or a salt thereof | |
| ZA704998B (en) | Pharmaceutical compositions | |
| IL33167A0 (en) | Pharmaceutical compositions containing a 4-phenyl-isonipecotic acid derivative | |
| ZA705963B (en) | Pharmaceutical compositions containing a tetramethylalkanediol or ester thereof | |
| IL34158A (en) | Adamantylcarboxamidophenylacetic acid and its derivatives, their preparation and pharmaceutical compositions containing them | |
| CA803520A (en) | Pharmaceutical compositions containing hydroxycinnamic acid derivatives | |
| IL35232A0 (en) | New anticonvulsive pharmaceutical compositions containing a benzafuran derivative | |
| IL35393A0 (en) | Antibacterial compositions containing a borinic acid derivative | |
| ZA695903B (en) | Pharmaceutical compositions | |
| ZA727855B (en) | Pharmaceutical compositions containing a 2-p-chlorophenoxy-2-methylpropronic acid or a derivative and a tocopherol | |
| IL36009A0 (en) | Pharmaceutical compositions containing 9-azolyl-(1)-fluorene-9-carboxylic acid derivatives | |
| CA829875A (en) | Pharmaceutical compositions containing 1-methyl-4-phenyl-4-piperidinol |